.png)
Nanomedicine Market By Product, Type and Application - Global Industry Analysis And Forecast To 2027
Published On : December 2018 Pages : 140 Category: Pharmaceuticals Report Code : HC122205
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Nanomedicine Market By Product (Vaccines, Therapeutics, In-vitro diagnostics, Regenerative medicine and In-vivo diagnostics) Type (Nano devices, Nanoparticles, Nanotubes and Nanoshells) and Application (Orthopedics, Clinical Oncology, Clinical Cardiology, Infectious diseases and Others) - Global Industry Analysis And Forecast To 2027
Industry Outlook
Nanomedicine is a field of medicine which uses knowledge and tools of nanotechnology & biology for prevention and treatment of disorders. Nanomedicine includes the use of nanscale elements like nano robots and biocompatible nanoparticles for diagnosis, delivering and sensing of living organisms. Nanomedicine with research and development is providing tools and clinically useful devices in near future. Nanomedicine field is growing due to; increasing in the spending by the government, increasing number of devices developed by extensive R&D for diagnostics & therapeutic sector, increase in products developed based on nanomolecules and other technologies, providing rising options for removal of genetic problems, etc. Therefore, the Nanomedicine Market is anticipated to expand and has tremendous scope during the forecast period. The global Nanomedicine Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
The global Nanomedicine Market is based on segment, by Product the market is segmented into Vaccines, Therapeutics, In-vitro diagnostics, Regenerative medicine and In-vivo diagnostics; by Type the market is segmented into Nanodevices, Nanoparticles, Nanotubes and Nanoshells; and by Application the market is segmented into Orthopedics, Clinical Oncology, Clinical Cardiology, Infectious diseases and Others.
- Nanomedicine Market, By Product
- Vaccines
- Therapeutics
- In-vitro diagnostics
- Regenerative medicine
- In-vivo diagnostics
- Nanomedicine Market, By Type
- Nanodevices
- Nanoparticles
- Nanotubes
- Nanoshells
- Nanomedicine Market, By Application
- Orthopedics
- Clinical Oncology
- Clinical Cardiology
- Infectious diseases
- Others
Regional Insights
On a global front, the Nanomedicine Market covers North America (United States, Canada and Mexico), Europe (Germany, UK, France, Russia, Italy, Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific), South America (Brazil, Argentina, Columbia, Rest of South America) and Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA). North American region is leading the Nanomedicine Market due to tie-ups between industries and various start-ups.
Nanomedicine Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The leading players in the market are Nanosphere Inc., Pfizer Inc., Combimatrix Corp, Merck & Co. Inc., Celgene Corporation, GE Healthcare, Ablynx NV, Arrowhead Research, Teva Pharmaceutical Industries Ltd. and Abraxis Bioscience Inc. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Nanosphere Inc.
- Pfizer Inc.
- Combimatrix Corp
- Merck & Co. Inc.
- Celgene Corporation
- GE Healthcare
- Ablynx NV
- Arrowhead Research
- Teva Pharmaceutical Industries Ltd.
- Abraxis Bioscience Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Nanomedicine Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Vaccines
o Therapeutics
o In-vitro diagnostics
o Regenerative medicine
o In-vivo diagnostics
o Nanomedicine Market, By Type, Estimates and Forecast, 2017-2027 ($Million)
o Nanodevices
o Nanoparticles
o Nanotubes
o Nanoshells
o Nanomedicine Market, By Application, Estimates and Forecast, 2017-2027 ($Million)
o Orthopedics
o Clinical Oncology
o Clinical Cardiology
o Infectious diseases
o Others
o Nanomedicine Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Nanomedicine Market, By Country
o U.S. Nanomedicine Market
o Canada Nanomedicine Market
o Mexico Nanomedicine Market
o Europe
§ Europe Nanomedicine Market, By Country
o Germany Nanomedicine Market
o UK Nanomedicine Market
o France Nanomedicine Market
o Russia Nanomedicine Market
o Italy Nanomedicine Market
o Rest of Europe Nanomedicine Market
o Asia-Pacific
§ Asia-Pacific Nanomedicine Market, By Country
o China Nanomedicine Market
o Japan Nanomedicine Market
o South Korea Nanomedicine Market
o India Nanomedicine Market
o Southeast Asia Nanomedicine Market
o Rest of Asia-Pacific Nanomedicine Market
o South America
§ South America Nanomedicine Market, By Country
o Brazil Nanomedicine Market
o ArgentinaNanomedicine Market
o Columbia Nanomedicine Market
o Rest of South America Nanomedicine Market
o Middle East and Africa
§ Middle East and Africa Nanomedicine Market, By Country
o Saudi Arabia Nanomedicine Market
o UAE Nanomedicine Market
o Egypt Nanomedicine Market
o Nigeria Nanomedicine Market
o South Africa Nanomedicine Market
o Rest of MEA Nanomedicine Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Nanomedicine Market, By Product
5.1. Introduction
5.2. Global Nanomedicine Revenue and Market Share by Product (2017-2027)
5.2.1. Global Nanomedicine Revenue and Revenue Share by Product (2017-2027)
5.3. Vaccines
5.3.1. Global Vaccines Revenue and Growth Rate (2017-2027)
5.4. Therapeutics
5.4.1. Global Therapeutics Revenue and Growth Rate (2017-2027)
5.5. In-vitro diagnostics
5.5.1. Global In-vitro diagnostics Revenue and Growth Rate (2017-2027)
5.6. Regenerative medicine
5.6.1. Global Regenerative medicine Revenue and Growth Rate (2017-2027)
5.7. In-vivo diagnostics
5.7.1. Global In-vivo diagnostics Revenue and Growth Rate (2017-2027)
6. Nanomedicine Market, By Type
6.1. Introduction
6.2. Global Nanomedicine Revenue and Market Share by Type (2017-2027)
6.2.1. Global Nanomedicine Revenue and Revenue Share by Type (2017-2027)
6.3. Nano devices
6.3.1. Global Nano devices Revenue and Growth Rate (2017-2027)
6.4. Nanoparticles
6.4.1. Global Nanoparticles Revenue and Growth Rate (2017-2027)
6.5. Nanotubes
6.5.1. Global Nanotubes Revenue and Growth Rate (2017-2027)
6.6. Nanoshells
6.6.1. Global Nanoshells Revenue and Growth Rate (2017-2027)
7. Nanomedicine Market, By Application
7.1. Introduction
7.2. Global Nanomedicine Revenue and Market Share by Application (2017-2027)
7.2.1. Global Nanomedicine Revenue and Revenue Share by Application (2017-2027)
7.3. Orthopedics
7.3.1. Global Orthopedics Revenue and Growth Rate (2017-2027)
7.4. Clinical Oncology
7.4.1. Global Clinical Oncology Revenue and Growth Rate (2017-2027)
7.5. Clinical Cardiology
7.5.1. Global Clinical Cardiology Revenue and Growth Rate (2017-2027)
7.6. Infectious diseases
7.6.1. Global Infectious diseases Revenue and Growth Rate (2017-2027)
7.7. Others
7.7.1. Global Others Revenue and Growth Rate (2017-2027)
8. Nanomedicine Market, By Region
8.1. Introduction
8.2. Global Nanomedicine Revenue and Market Share by Regions
8.2.1. Global Nanomedicine Revenue by Regions (2017-2027)
8.3. North America Nanomedicine by Countries
8.3.1. North America Nanomedicine Revenue and Growth Rate (2017-2027)
8.3.2. North America Nanomedicine Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Nanomedicine by Countries
8.4.1. Europe Nanomedicine Revenue and Growth Rate (2017-2027)
8.4.2. Europe Nanomedicine Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Nanomedicine by Countries
8.5.1. Asia-Pacific Nanomedicine Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Nanomedicine Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Nanomedicine by Countries
8.6.1. South America Nanomedicine Revenue and Growth Rate (2017-2027)
8.6.2. South America Nanomedicine Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Nanomedicine by Countries
8.7.1. Middle East and Africa Nanomedicine Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Nanomedicine Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Nanosphere Inc.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Pfizer Inc.
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. Combimatrix Corp
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Merck & Co. Inc.
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Celgene Corporation
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. GE Healthcare
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. Ablynx NV
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. Arrowhead Research
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. Teva Pharmaceutical Industries Ltd.
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
9.10. Abraxis Bioscience Inc.
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Revenue and Market Share
10. Global Nanomedicine Market Competition, by Manufacturer
10.1. Global Nanomedicine Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Nanomedicine Price By Region (2017-2017)
10.3. Top 5 Nanomedicine Manufacturer Market Share
10.4. Market Competition Trend
11. Nanomedicine Market Forecast (2017-2027)
11.1. Global Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Nanomedicine Market Forecast by Regions (2017-2027)
11.2.1. North America Nanomedicine Market Forecast (2017-2027)
11.2.1.1. United States Nanomedicine Market Forecast (2017-2027)
11.2.1.2. Canada Nanomedicine Market Forecast (2017-2027)
11.2.1.3. Mexico Nanomedicine Market Forecast (2017-2027)
11.2.2. Europe Nanomedicine Market Forecast (2017-2027)
11.2.2.1. Germany Nanomedicine Market Forecast (2017-2027)
11.2.2.2. France Nanomedicine Market Forecast (2017-2027)
11.2.2.3. UK Nanomedicine Market Forecast (2017-2027)
11.2.2.4. Russia Nanomedicine Market Forecast (2017-2027)
11.2.2.5. Italy Nanomedicine Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Nanomedicine Market Forecast (2017-2027)
11.2.3. Asia-Pacific Nanomedicine Market Forecast (2017-2027)
11.2.3.1. China Nanomedicine Market Forecast (2017-2027)
11.2.3.2. Japan Nanomedicine Market Forecast (2017-2027)
11.2.3.3. Korea Nanomedicine Market Forecast (2017-2027)
11.2.3.4. India Nanomedicine Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Nanomedicine Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Nanomedicine Market Forecast (2017-2027)
11.2.4. South America Nanomedicine Market Forecast (2017-2027)
11.2.4.1. Brazil Nanomedicine Market Forecast (2017-2027)
11.2.4.2. Argentina Nanomedicine Market Forecast (2017-2027)
11.2.4.3. Columbia Nanomedicine Market Forecast (2017-2027)
11.2.4.4. Rest of South America Nanomedicine Market Forecast (2017-2027)
11.2.5. Middle East and Africa Nanomedicine Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Nanomedicine Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Nanomedicine Market Forecast (2017-2027)
11.2.5.3. Egypt Nanomedicine Market Forecast (2017-2027)
11.2.5.4. Nigeria Nanomedicine Market Forecast (2017-2027)
11.2.5.5. South Africa Nanomedicine Market Forecast (2017-2027)
11.2.5.6. Turkey Nanomedicine Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Nanomedicine Market Forecast (2017-2027)
11.3. Nanomedicine Market Forecast by Product (2017-2027)
11.3.1. Nanomedicine Forecast by Product (2017-2027)
11.3.2. Nanomedicine Market Share Forecast by Product (2017-2027)
11.4. Nanomedicine Market Forecast by Type (2017-2027)
11.4.1. Nanomedicine Forecast by Type (2017-2027)
11.4.2. Nanomedicine Market Share Forecast by Type (2017-2027)
11.5. Nanomedicine Market Forecast by Application (2017-2027)
11.5.1. Nanomedicine Forecast by Application (2017-2027)
11.5.2. Nanomedicine Market Share Forecast by Application (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Nanomedicine Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Nanomedicine Revenue and Revenue Share by Product (2017-2018)
Figure Global Vaccines Revenue and Growth Rate (2017-2018)
Figure Global Therapeutics Revenue and Growth Rate (2017-2018)
Figure Global In-vitro diagnostics Revenue and Growth Rate (2017-2018)
Figure Global Regenerative medicine Revenue and Growth Rate (2017-2018)
Figure Global In-vivo diagnostics Revenue and Growth Rate (2017-2018)
Table Global Nanomedicine Revenue and Revenue Share by Type (2017-2018)
Figure Global Nano devices Revenue and Growth Rate (2017-2018)
Figure Global Nanoparticles Revenue and Growth Rate (2017-2018)
Figure Global Nanotubes Revenue and Growth Rate (2017-2018)
Figure Global Nanoshells Revenue and Growth Rate (2017-2018)
Table Global Nanomedicine Revenue and Revenue Share by Application (2017-2018)
Figure Global Orthopedics Revenue and Growth Rate (2017-2018)
Figure Global Clinical Oncology Revenue and Growth Rate (2017-2018)
Figure Global Clinical Cardiology Revenue and Growth Rate (2017-2018)
Figure Global Infectious diseases Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Nanomedicine Revenue by Regions (2017-2018)
Figure North America Nanomedicine Growth Rate (2017-2018)
Figure North America Nanomedicine Revenue and Growth Rate (2017-2018)
Figure North America Nanomedicine by Countries (2017-2018)
Figure North America Nanomedicine Revenue (Million USD) by Countries (2017-2018)
Figure United States Nanomedicine Growth Rate (2017-2018)
Figure United States Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Nanomedicine Growth Rate (2017-2018)
Figure Canada Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Nanomedicine Growth Rate (2017-2018)
Figure Mexico Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Nanomedicine Growth Rate (2017-2018)
Figure Europe Nanomedicine Revenue and Growth Rate (2017-2018)
Figure Europe Nanomedicine by Countries (2017-2018)
Figure Europe Nanomedicine Revenue (Million USD) by Countries (2017-2018)
Figure Germany Nanomedicine Growth Rate (2017-2018)
Figure Germany Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Nanomedicine Growth Rate (2017-2018)
Figure France Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Nanomedicine Growth Rate (2017-2018)
Figure UK Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Nanomedicine Growth Rate (2017-2018)
Figure Russia Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Nanomedicine Growth Rate (2017-2018)
Figure Italy Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Nanomedicine Growth Rate (2017-2018)
Figure Rest of Europe Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Nanomedicine Growth Rate (2017-2018)
Figure Asia-Pacific Nanomedicine Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Nanomedicine by Countries (2017-2018)
Figure Asia-Pacific Nanomedicine Revenue (Million USD) by Countries (2017-2018)
Figure China Nanomedicine Growth Rate (2017-2018)
Figure China Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Nanomedicine Growth Rate (2017-2018)
Figure Japan Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Nanomedicine Growth Rate (2017-2018)
Figure Korea Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Nanomedicine Growth Rate (2017-2018)
Figure India Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Nanomedicine Growth Rate (2017-2018)
Figure Southeast Asia Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Nanomedicine Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Nanomedicine Growth Rate (2017-2018)
Figure South America Nanomedicine Revenue and Growth Rate (2017-2018)
Figure South America Nanomedicine by Countries (2017-2018)
Figure South America Nanomedicine Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Nanomedicine Growth Rate (2017-2018)
Figure Brazil Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Nanomedicine Growth Rate (2017-2018)
Figure Argentina Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Nanomedicine Growth Rate (2017-2018)
Figure Columbia Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Nanomedicine Growth Rate (2017-2018)
Figure Rest of South America Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Nanomedicine Growth Rate (2017-2018)
Figure Middle East and Africa Nanomedicine Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Nanomedicine by Countries (2017-2018)
Figure Middle East and Africa Nanomedicine Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Nanomedicine Growth Rate (2017-2018)
Figure Saudi Arabia Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Nanomedicine Growth Rate (2017-2018)
Figure United Arab Emirates Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Nanomedicine Growth Rate (2017-2018)
Figure Egypt Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Nanomedicine Growth Rate (2017-2018)
Figure Nigeria Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Nanomedicine Growth Rate (2017-2018)
Figure South Africa Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Nanomedicine Growth Rate (2017-2018)
Figure Turkey Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Nanomedicine Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Nanomedicine Revenue (Millions USD) and Growth Rate (2017-2018)
Table Nanosphere Inc. Nanomedicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Inc. Nanomedicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Combimatrix Corp Nanomedicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Merck & Co. Inc. Nanomedicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Celgene Corporation Nanomedicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GE Healthcare Nanomedicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Ablynx NV Nanomedicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Arrowhead Research Nanomedicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Teva Pharmaceutical Industries Ltd. Nanomedicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Abraxis Bioscience Inc. Nanomedicine Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Nanomedicine Market Share by Manufacturer
Figure Global Nanomedicine Revenue and Market Share by Manufacturer
Table Global Nanomedicine Price by Region (2017-2017)
Figure Top 5 Nanomedicine Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Nanomedicine Revenue (Millions USD) and Growth Rate (2018-2025)
Table Nanomedicine Market Forecast by Regions (2018-2025)
Figure North America Nanomedicine Market Forecast (2018-2025)
Figure United States Nanomedicine Market Forecast (2018-2025)
Figure Canada Nanomedicine Market Forecast (2018-2025)
Figure Mexico Nanomedicine Market Forecast (2018-2025)
Figure Europe Nanomedicine Market Forecast (2018-2025)
Figure Germany Nanomedicine Market Forecast (2018-2025)
Figure France Nanomedicine Market Forecast (2018-2025)
Figure UK Nanomedicine Market Forecast (2018-2025)
Figure Russia Nanomedicine Market Forecast (2018-2025)
Figure Italy Nanomedicine Market Forecast (2018-2025)
Figure Rest of Europe Nanomedicine Market Forecast (2018-2025)
Figure Asia-Pacific Nanomedicine Market Forecast (2018-2025)
Figure China Nanomedicine Market Forecast (2018-2025)
Figure Japan Nanomedicine Market Forecast (2018-2025)
Figure Korea Nanomedicine Market Forecast (2018-2025)
Figure India Nanomedicine Market Forecast (2018-2025)
Figure Southeast Asia Nanomedicine Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Nanomedicine Market Forecast (2018-2025)
Figure South America Nanomedicine Market Forecast (2018-2025)
Figure Brazil Nanomedicine Market Forecast (2018-2025)
Figure Argentina Nanomedicine Market Forecast (2018-2025)
Figure Columbia Nanomedicine Market Forecast (2018-2025)
Figure Rest of South America Nanomedicine Market Forecast (2018-2025)
Figure Middle East and Africa Nanomedicine Market Forecast (2018-2025)
Figure Saudi Arabia Nanomedicine Market Forecast (2018-2025)
Figure United Arab Emirates Nanomedicine Market Forecast (2018-2025)
Figure Egypt Nanomedicine Market Forecast (2018-2025)
Figure Nigeria Nanomedicine Market Forecast (2018-2025)
Figure South Africa Nanomedicine Market Forecast (2018-2025)
Figure Turkey Nanomedicine Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Nanomedicine Market Forecast (2018-2025)
Figure Global Nanomedicine Forecast by Product (2018-2025)
Figure Global Nanomedicine Market Share Forecast by Product (2018-2025)
Figure Global Nanomedicine Forecast by Product (2018-2025)
Figure Global Nanomedicine Forecast by Type (2018-2025)
Figure Global Nanomedicine Market Share Forecast by Type (2018-2025)
Figure Global Nanomedicine Forecast by Type (2018-2025)
Figure Global Nanomedicine Forecast by Application (2018-2025)
Figure Global Nanomedicine Market Share Forecast by Application (2018-2025)
Figure Global Nanomedicine Forecast by Application (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|